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Abstract
Purpose: Caffeine ingestion is widely accepted for its ergogenic properties. Recent
evidence suggests that mouth rinsing with caffeine prior to exercise can improve short
duration sprint performance. The purpose of this study was to examine whether the
benefits of caffeine mouth rinsing can be extended to include sustained high intensity
performance and whether a caffeine rinse can provide additive value to the performance
benefits of caffeine intake (i.e. caffeine ingestion plus caffeine rinse > caffeine
ingestion). Methods: 25 recreational cyclists performed six separate 3-km time trials (2
familiarization and 4 treatment trials), each trial separated by 3-7 days. Subjects were
given a combination of caffeine and placebo capsules (6mg/kg body weight taken one
hour prior to trial) and mouth-rinses (1.2% weight/volume administered immediately
prior). Thus, the treatments were: PLA-PLA, PLA-CAF, CAF-CAF, CAF-PLA (capsulemouth-rinse). Treatments were provided in a randomized, counterbalanced, double
blind, placebo controlled fashion. Magnitude-based qualitative inferences were applied
to evaluate treatment differences. Results: Caffeine ingestion led to better cycling
performance, as CAF-CAF and CAF-PLA treatments both ‘likely’ improved performance
time by 1.4% and 1.7% compared to PLA-PLA, while also improving average power
output. The effects of the caffeine mouth-rinse on 3-km time trial performance were
unclear compared to placebo conditions. Conclusion: Caffeine ingestion enhanced
short, high intensity cycling time trial performance, while the caffeine mouth-rinse had
unclear effects. Collectively, these data confirm that caffeine ingestion is useful as an
ergogenic aid for high intensity cycling, while a caffeine mouth-rinse does not appear to
have similar ergogenic effects.
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Chapter 1
Introduction
Caffeine is widely recognized as a performance-enhancing agent. Initial
evidence for the performance benefit of caffeine intake was demonstrated by Costill
(1977) who reported that 330 mg of caffeine extended cycling time to exhaustion (80%
VO2max) by approximately 20%. Subsequent research has confirmed this finding
(Pasman, 1995, Cole, 1996; Greer, 2000; Jenkins, 2008; and McNaughton, 2008). More
recent work has indicated that caffeine can also improve power output during anaerobic
exercise (Bell et al., 2001), as well as repeated sprint performance (Beaven et al.,
2012). Many of these studies also indicated that caffeine intake elevated blood lactate
and heart rate, either as a direct effect of the caffeine or as a function of being able to
perform at higher intensities (Anselme et al., 1992). However, it is unlikely that caffeine
raises blood lactate because of increased anaerobic glycolysis, as a number of studies
have shown increased blood lactate without increased muscle lactate (Erickson, 1987
and Bell, 2002). It is worth noting that the performance benefits of caffeine have not
been consistently reported (Bell, 1998, Doherty, 2002, and Beck, 2008). Though it is
clear that not all individuals favorably respond to caffeine under all conditions, on
balance caffeine appears to deliver considerable performance benefits.
Though the physiological mechanisms responsible for the ergogenic effect of
caffeine are not completely understood, one plausible explanation involves CNS
stimulation. Following liver metabolism, caffeine can readily cross the blood-brain
barrier due to its lipophilic nature (Davis, 2003 and McCall, 1982), whereby it
antagonizes adenosine, an inhibitory neurotransmitter. Thus, caffeine has been shown
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to counteract many of the inhibitory effects of adenosine, consequently enhancing
neuroexcitability, neurotransmitter release, and arousal (Davis, 2003). Likely through
this mechanism, pre-exercise caffeine intake can decrease perception of effort and by
extension can lead to greater workloads when riding at a fixed perceived exertion (RPE)
(Cole, 1996). A separate and less likely mechanism for caffeine-induced performance
gains is the idea that caffeine can create a more favorable intracellular environment in
working skeletal muscles (Graham, 2001). This is theoretically accomplished by
maintaining electrolyte homeostasis, which perhaps would increase force production per
motor unit and/or increase motor unit recruitment during exercise. However, this theory
has been called into question (Davis, 2003 and Jenkins, 2008).
Like many drugs that target the central nervous system (i.e. ephedrine,
amphetamine, and nicotine), caffeine ingestion can elicit a number of negative side
effects. Large doses of caffeine can increase the risk of hypovolemia given the
purported diuretic effects of caffeine (Bytomski and Parker, 2011). Large doses of
caffeine can also lead to symptoms such as nervousness, irritability, muscle twitching,
heart palpitations, and respiratory alkalosis (Bytomski and Parker, 2011). It should also
be noted that regularly using caffeine intake prior to exercise can induce a tolerance
adaptation; meaning higher doses are required to elicit the same ergogenic effect
(Bytomski and Parker, 2011), perhaps amplifying certain side effects.
Interestingly, there is recent evidence that caffeine can benefit performance
without using traditional means of ingestion. For example, chewing caffeinated gum
immediately prior to exercise improved repeated sprint performance (Paton et al.,
2010). A similar study reported that a caffeine solution rinsed in the mouth immediately
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prior to exercise (without ingestion) elicited a rapid increase in maximal voluntary power
production (Beaven et al., 2012). Although the mechanism through which sprint
performance was improved is unclear, it may be similar to what has been demonstrated
with the mouth rinsing of carbohydrate. For example, Carter (2004) found that a
carbohydrate mouth-rinse had a positive effect on 1-hour time trial cycling performance,
while Rollo (2008) observed an increase in total distance covered during a 30-minute
run when rinsing with a carbohydrate rinse vs. a placebo rinse. Together these data
support the presence of oropharyngeal caffeine receptors that may be providing
feedback to the brain, thereby eliciting an excitatory effect. One of the possible benefits
of a caffeine mouth-rinse treatment as opposed to caffeine ingestion is that the rinse
should minimize many of the negative systemic side effects of caffeine, since the rinse
would be affecting the body neurally, not systemically. Similarly, because some authors
have reported that caffeine has no effect on high intensity cycling performance (Bell,
1998, Jacobson et al., 2001, and Doherty, 2002), a caffeine mouth-rinse may be able to
elicit ergogenic benefits to individuals who fail to respond to caffeine ingestion.
While the findings of Paton and Beaven highlighted above provide initial support
for the possible benefits of a caffeine mouth-rinse (Paton, 2010 and Beaven, 2012), it is
unknown whether a caffeine mouth-rinse influences sustained high intensity
performance. Similarly, the possibility that caffeine ingestion and mouth rinse could
enhance performance more than either one alone has not yet been examined. As a
result, the purpose of this investigation was to determine whether or not rinsing with
caffeine enhances 3-km cycling performance, while also investigating the potentially
added benefit of both ingesting and rinsing with caffeine prior to high intensity cycling.
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Chapter 2
Methodology
Subjects:
Twenty-five recreationally active college-aged males and females were recruited
from James Madison University and the surrounding Harrisonburg area. Subject
characteristics are described in Table 1. Subjects were free of medications and at
minimum performed intermittent cycling over the past two months. Subjects were
provided with written and verbal information about the experimental procedures and
potential risks prior to completing the informed consent. The James Madison University
Institutional Review Board approved all procedures.

Experimental Overview:
Familiarization and Treatment Trials
Subjects performed six separate 3-km cycling time trials on a computerized
Racermate Veletron bicycle ergometer (Seattle, WA). Each trial was separated by 3-7
days and all were completed at the same time of day (2 hours). The two initial trials
were familiarization trials to minimize any training or learning effect that would occur
during the subsequent experimental trials. The remaining four visits included four
experimental trials where separate treatments were provided in a randomized,
counterbalanced, double blind, placebo controlled fashion. Subjects were encouraged
to treat each trial as a competition. Subjects did not receive any verbal feedback or
encouragement during the trials, and only elapsed distance was displayed on the
computer monitor. The primary dependant measures were time to complete the 3-km
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time trial and average power output. Further, time and average power output were
calculated for each 1-km increment to assess any influence that caffeine may have had
on pacing strategy.

Treatments
No treatments were provided during the familiarization trials, with the exception
of a pre-exercise practice mouth rinse (water). The experimental trials included the
following treatments: 1. Caffeine mouth rinse (PLA-CAF); mouth rinse solution
administered immediately prior to- and during exercise where subjects were instructed
to only rinse the caffeine solution in their mouths and then spit it out (without
swallowing). A placebo pill was also administered 1 hour prior to exercise. 2. Caffeine
pill (CAF-PLA); subjects ingested a caffeine pill (6mg/kg body weight) whole (to avoid
any contact with oral receptors) 1 hour prior to exercise. A placebo mouth rinse solution
was also administered. 3. Caffeine pill + caffeine mouth rinse (CAF-CAF); a caffeine pill
and caffeine mouth rinse were administered. 4. Placebo (PLA-PLA); a placebo pill and
placebo mouth rinse were administered. When reporting different treatment types, ‘PLA’
and ‘CAF’ are used for simplicities sake. The first letters represent the capsule
treatment, while the second represent the mouth-rinse treatment. Thus, PLA-CAF would
represent the PLA capsule and CAF mouth-rinse, and so on.
All mouth rinses (25 ml) were administered in Dixie cups and were comprised of
saccharine (Sweet N’ Low) and water with or without caffeine (1.2% weight/volume).
Rinses were provided 5 minutes prior to the time trial and again 30 seconds prior to the
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time trial. The solution was swished around in the mouth for 5 seconds, upon which it
was expectorated.
Dietary, Exercise, and Time of Day Controls:
Subjects recorded food intake 24 hours prior to their first experimental trial. The
subjects were then provided with a copy of their initial dietary log, which they were
instructed to replicate for the 24 hrs preceding each subsequent experimental trial.
Additionally, subjects abstained from any alcohol and caffeine for 24 hours and 12
hours prior to the experimental trials, respectively. Finally, subjects avoided food intake
for 2 hours preceding each experimental trial.
Subjects also refrained from heavy/unaccustomed exercise for 48 hrs prior to
each experimental trial, recorded all physical activity performed during this time frame,
and maintain consistent exercise habits between trials. All experimental trials were
separated by 3-7 days and performed at the same time of day (within a 2-hour range).

Statistics:
Univariate Analysis of Variance (ANOVA) was applied to determine treatment
differences for all variables. Simple contrasts between treatment conditions were used
to generate P values for subsequent analysis as described below. Statistical analyses
were performed using IBM Statistical Package for Social Sciences (SPSS) 21 for
Macintosh (SPSS Inc., Chicago, IL, USA).
Magnitude-based inferences about the data were derived using methods
described by Hopkins and colleagues (Hopkins et al., 2009). A previously established
‘smallest worthwhile change’ in performance was used as the threshold value for a

12

substantial treatment effect (separate treatment conditions vs. placebo) (Hopkins,
2004). The smallest worthwhile change in performance has been defined as 0.3 x the
within subject variability across repeated time trials (Hopkins, 2004). The coefficients of
variability for the performance parameters were derived from the familiarization trials of
the current investigation.
A published spreadsheet (Hopkins, 2007) was then used to determine the
likelihoods of the true treatment effect (of the population) reaching the substantial
change threshold (0.3 x CV); these were classified as <1% almost certainly no chance,
1-5% = very unlikely, 5-25% = unlikely, 25-75% = possible, 75-95% = likely, 95-99% =
very likely, and >99% = almost certain. If the percent chance of the effect reaching the
substantial change threshold was <25% and the effect was clear, it was classified as a
‘trivial’ effect. If 90% confidence intervals included values that exceeded the substantial
change threshold for both a positive and negative effect, effects were classified as
unclear (>5% chance of reaching the substantial threshold for both a positive and
negative effect). For ease of interpretation data are displayed as raw means ± SD.
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Table 2.1 Subject Characteristics

Age (yrs)

Height (cm)

Weight (kg)

Recent Physical Activity
(Days/Week)

Weekly Caffeine Usage
(Servings of Coffee + Soda)

Male (n = 17)

21.1  1.7

169  30

81.2  21.3

4.9  1.5

3.8  5.3

Female (n = 8)

21.1  1.8

163  9

57.9  7.2

5.3  1.1

6.8  9.3

Total (n = 25)

21.1  1.7

167  25

73.8  21.0

5.0  1.4

4.8  6.8

Data are displayed as means  SD
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Chapter 3
Results
Average performance times and power output for all treatment conditions and
qualitative inferences about treatment comparisons are displayed in Tables 3.1 and 3.2.
CAF-CAF and CAF-PLA treatments both ‘likely’ improved performance time by 1.4%
and 1.7% compared to PLA-PLA. It was unclear whether the PLA-CAF treatment had
any effect on 3-km time trial performance compared to PLA-PLA. When compared to
the PLA-CAF treatment, CAF-PLA had a ‘very likely’ beneficial effect on performance
time (96.9% likelihood), improving finishing time by 1.9%. When looking at the
statistical outcomes for each split time, PLA-CAF ‘likely’ improved performance time in
both the second and third split when compared to PLA-PLA. Similarly, CAF-CAF
treatment also ‘likely’ improved performance time for the 3-km split compared to PLAPLA.
Mean 3-km power outputs are shown in Table 3.2. Mean power output for CAFCAF and CAF-PLA were improved by 4.6% and 4.5%, respectively, when compared to
the PLA-PLA treatment. There was no significant difference in average power outputs in
PLA-CAF treatment when compared to PLA-PLA.
Individual data for the 3-km times are also displayed in Figures 3.1 and 3.2. Note
that data points below the line of identity reflect an improvement in 3-km time in the
CAF-PLA or PLA-CAF trials. 18 out of 25 individuals performed better after caffeine
ingestion (CAF-PLA vs. PLA-PLA), whereas only 12 out of 25 performed faster with the
caffeine mouth-rinse (PLA-CAF vs. PLA-PLA).
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Table 3.1. 3-km Time Trial Performance – Qualitative Inferences
Comparison

Time Difference (sec)
 90% CL

Clinical Inference

PLA-PLA vs. PLA-CAF

-0.82  3.4

Unclear

PLA-PLA vs. CAF-CAF

4.3  3.3

CAF-CAF Likely Beneficial
(84.8% likelihood)

PLA-PLA vs. CAF-PLA

5.1  3.3

CAF-PLA Likely Beneficial
(92.4% likelihood)

PLA-CAF vs. CAF-CAF

5.2  4.6

CAF-CAF Likely Beneficial
(84.8% likelihood)

PLA-CAF vs. CAF-PLA

6.0  3.2

CAF-PLA Very Likely Beneficial
(96.9% likelihood)

CAF-CAF vs. CAF-PLA

-0.80  3.4

Unclear

Data are displayed as means  SD
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Table 3.2 3-km Time Trial Finishing Time and Split Times for 1-km, 2-km, and 3-km During 3-km-Time Trial
Total 3 Kilometer

Kilometer 1

Kilometer 2

Kilometer 3

PLA-PLA

309.5  29.5
(239  55 W)

101.2  11.5
(261  67 W)

105.3  9.7
(223  50 W)

103.1  9.7
(238  59 W)

PLA-CAF

310.3  28.2
(237  53 W)

102.8  11.9
(248  68 W)

104.9  9.2
(225  50 W)

102.6  9.4
(241  59 W)

CAF-CAF

305.2  24.7a
(250  45 W)

98.5  8.2c
(273  59 W)

103.0  7.4e
(233  43 W)

101.2  8.2g
(249  53 W)

CAF-PLA

304.4  28.3b
(250  58 W)

99.7  9.8d
(267  63 W)

103.2  9.6f
(236  55 W)

101.5  10.0h
(248  63 W)

aCAF-CAF

vs. PLA-PLA Likely (84.8%); bCAF-PLA vs. PLA-PLA Likely (92.4%); cCAF-CAF vs. PLA-PLA Possible
(47.6%);
vs. PLA-PLA Possible (43.2%); eCAF-CAF vs. PLA-PLA Possible (73.3%); fCAF-PLA vs. PLA-PLA
Likely (93.3%); gCAF-CAF vs. PLA-PLA Likely (81.3%); hCAF-PLA vs. PLA-PLA Very Likely (96.4%). All other treatment
comparisons were unclear.
dCAF-PLA
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Figure 3.1. 3-km Finishing Times – Individual Responses – Caffeine Mouth Rinse (PLA-CAF) Compared to
Placebo Conditions (PLA-PLA). The line of identity reflects no difference between the two trials. Data points below the
line of identity reflect an improved 3-km time in the PLA-CAF condition.
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Figure 3.2. 3-km Finishing Times – Individual Responses – Caffeine Capsule (CAF-PLA) Compared to Placebo
Conditions (PLA-PLA). The line of identity is plotted and reflects no difference between the two trials. Data points below
the line of identity reflect an improved 3-km time in the CAF-PLA condition.
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Chapter 4
Discussion
We assessed 3-km time trial performance in response to a combination of
caffeine ingestion and caffeine mouth-rinse treatments. As hypothesized, caffeine
capsule intake ‘very likely’ improved 3-km TT performance, evidenced by 1.4% and
1.7% improvements in both caffeine capsule trials. This finding is consistent with a large
body of literature. The most novel aspect of this investigation was the inclusion of the
mouth-rinse conditions. Our results indicate that the performance effect of caffeine
mouth rinsing is unclear. Likewise, the addition of the caffeine mouth in the trials where
subjects had already consumed a caffeine capsule failed to elicit a clear effect.
Very few studies have evaluated the impact of a caffeine mouth-rinse prior to
exercise, with only one study observing potential benefits from this strategy (Beaven et
al., 2012). Beaven (2012) reported that a caffeine mouth-rinse solution administered
immediately prior to exercise rapidly enhanced maximal voluntary power production.
Differences in experimental conditions and subject characteristics may be responsible
for the contrasting results. It may be that caffeine mouth rinse increases excitatory drive
for a brief period of time that does not translate to longer sustained performances. This
is reinforced by a recent report that caffeine mouth rinsing does not impart performance
benefits in a performance protocol lasting around 1 hour (Doering, 2013). Similar to our
findings, Doering observed no significant improvement in cycling time trial performance
from a caffeine mouth-rinse (3918243s) compared to placebo (3940227s) (Doering,
2013). When combined with the previous related literature, caffeine mouth rinse may
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facilitate a brief improvement in power output that does not translate to events lasting
longer than ~3 minutes.
An additional possibility for the lack of a performance effect with caffeine mouth
rinsing is the confounding effect of previous caffeine habits. A number of studies have
investigated the benefits of caffeine ingestion prior to exercise in habitual caffeine users
versus non-users. Early work indicated that habitually high caffeine users acquire a
tolerance to caffeine, reducing its effects during prolonged exercise (Fisher, 1986). Bell
et al. (2002) observed similar effects, as both duration and magnitude of the ergogenic
effect following caffeine ingestion was greater in caffeine nonusers compared to users.
Other studies have confirmed these findings (Tarnolpolsky et al., 1989 and Van Soeren
et al., 1993). In concert with this phenomenon, Beaven noted that subjects self-reported
as light caffeine users (Beaven, 2012) in the aforementioned study that observed and
increase in peak power following a caffeine mouth rinse. Moreover, a subset of nonusers responded favorably to the caffeine mouth rinse administered by Doering,
whereas users were not influenced by the caffeine rinse. While not systematically
addressed, it is possible that we happened to recruit a large number of heavy users of
caffeine, thereby blunting any potential response to the mouth-rinse. However, this is
somewhat unlikely because we did find an overall improvement in the caffeine capsule
times versus the placebo (18/25 subjects performed better with caffeine ingestion alone,
indicating our study had an adequate number of ‘responders’ to caffeine).
Another explanation for the absence of a benefit with the caffeine rinse may be
related to the bitter taste of caffeine. While providing a bitter tasting placebo mouthrinse is one of the strengths of this investigation because of its indistinguishable taste
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from the caffeine mouth-rinse, recent data suggests that bitterness may also improve
performance. Gam (2014) found that when individuals rinsed a bitter tasting quinine
solution prior to a 30 second cycling sprint, mean power output was improved by 2.43.9% when compared to water, a sweet aspartame solution, or no solution at all.
Therefore, it is possible that the bitter taste of the placebo rinse actually enhanced
performance, thereby minimizing or masking any potential effect that the caffeine may
have elicited on its own.
While the effectiveness of a caffeine mouth-rinse remains unclear, it is evident
that a caffeine capsule ‘likely’ improved 3-km time trial performance. While few studies
found no improvements in performance with caffeine ingestion prior to exercise (Bell,
1998, Doherty, 2002, and Beck, 2008), the findings in this study were consistent with
the larger body of the literature (Costill, 1977; Pasman, 1995, Cole, 1996; Greer, 2000;
Jenkins, 2008; and McNaughton, 2008). However, only 18 of the 25 subjects
participating in this study performed better after caffeine capsule ingestion, meaning
that about 30 percent of individuals saw no benefit from taking a caffeine capsule prior
to their 3-km time trial. This is consistent with the number of non-responders reported in
prior work by Doherty (1998). Recent work suggests that a (C/A) single-nucleotide
polymorphism (variant allele at a single position) on the CYP1A2 gene (which encodes
for cytochrome p450, a key hepatic enzyme involved in caffeine metabolism) may
partially mediate the individual ergogenic response to caffeine consumption (Womack et
al., 2012). Specifically, caffeine significantly improved 40-km cycling time trial
performance in AA homozygotes (3.8 minutes) to a greater extent than C allele carriers
(1.3 minutes) (Womack, et al., 2012). This polymorphism and genetic variation is a
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possible reason as to why close to one-third of subjects in this study saw no benefit
from caffeine ingestion. Interestingly, of the 7 individuals that were non-responders to
the caffeine capsule, 5 also saw no effect from the caffeine mouth-rinse.
While this study presents several small limitations to the generalizability of our
findings, the double-blind, counterbalanced, and randomized design of our study
provides a strong basis for our conclusion that a caffeine mouth-rinse is of limited
ergogenic value. The present study demonstrates that a 1.2% weight/volume caffeine
mouth-rinse does not improve, nor impair TT cycling performance. However, caffeine
ingestion improved performance time in most individuals, and is a ‘likely’ beneficial
treatment prior to a 3-km time trial. Collectively, this data suggests that a majority of
individuals will benefit from caffeine ingestion prior to high intensity cycling, while very
few will benefit with a caffeine mouth-rinse alone. Further work should be done to better
profile the influence habitual caffeine usage has on the effects of a caffeine mouth-rinse,
as well as examine the genetic influence (if any) on the response to a caffeine mouthrinse.
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